Richard Drake to Disease Progression
This is a "connection" page, showing publications Richard Drake has written about Disease Progression.
Connection Strength
0.850
-
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics Clin Appl. 2013 Oct; 7(9-10):677-89.
Score: 0.334
-
Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry. Prostate. 2020 09; 80(13):1071-1086.
Score: 0.134
-
Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI-Imaging Mass Spectrometry. Proteomics Clin Appl. 2019 01; 13(1):e1700152.
Score: 0.120
-
Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma. PLoS One. 2016; 11(4):e0154074.
Score: 0.100
-
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology. 2005 Mar; 41(3):634-42.
Score: 0.046
-
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Sci Rep. 2017 06 22; 7(1):4020.
Score: 0.027
-
Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male Mice. Cancer Prev Res (Phila). 2016 06; 9(6):466-75.
Score: 0.025
-
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. 2015 Dec 22; 6(41):43743-58.
Score: 0.024
-
Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis. J Am Soc Nephrol. 2015 Jun; 26(6):1402-13.
Score: 0.022
-
Rhythmic pattern of PCA opioid demand in adults with cancer pain. Eur J Pain. 2010 Apr; 14(4):372-9.
Score: 0.016